Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease. (Q53329775)

13 May 2018

title

Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease. (English)

1 reference

13 May 2018

0 references

Angelis P

1

1 reference

13 May 2018

Scharf S

2

1 reference

13 May 2018

Mander A

3

1 reference

13 May 2018

Vajda F

4

1 reference

13 May 2018

Christophidis N

5

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 March 1998

1 reference

13 May 2018

published in

Neuroscience Letters

1 reference

13 May 2018

volume

244

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

106-108

1 reference

13 May 2018

The participation of interleukin-6 in the pathogenesis of alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

Interleukin-6: a cytokine for gerontologists

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

Circulating interleukin-6 receptor in patients with sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

The soluble interleukin-6 receptor is generated by shedding

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

The molecular pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

Purification and characterization of soluble human IL-6 receptor expressed in CHO cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

The hepatic interleukin-6 receptor Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2898%2900136-0

7 January 2021

10.1016/S0304-3940(98)00136-0

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

9572596

1 reference

13 May 2018